AKL Research & Development Ltd
Stevenage Bioscience Catalyst
Gunnels Wood Road
Stevenage, Herts SG1 2FX
Privacy Policy
Legal & Copyright
AKL Research & Development HomeAKL Research & Development - Who we are and Our VisionAKL Research & Development - PortfolioAKL Research & Development - Latest NewsAKL Research & Development - Contact Information
AKL is a disruptive biotech company developing pharmaceuticals for inflammatory conditions, which have significant unmet needs, via a "clinic-to-lab" model.
Developing novel synthetic drugs derived from natural products, where relevant activity has been observed, improves the risk profile of tolerability and efficacy.
AKL's lead candidate APPA is targeted for the treatment of osteoarthritis, a disease well recognised to have substantial unmet needs.
AKL's other inflammatory research activities include chronic obstructive pulmonary disease, atopic skin disease, irritable bowel syndrome, benign prostate hyperplasia.